InMed Pharmaceuticals (INM) Enterprise Value (2021 - 2025)
Historic Enterprise Value for InMed Pharmaceuticals (INM) over the last 5 years, with Q4 2025 value amounting to -$7.0 million.
- InMed Pharmaceuticals' Enterprise Value fell 2522.92% to -$7.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$7.0 million, marking a year-over-year decrease of 2522.92%. This contributed to the annual value of -$11.1 million for FY2025, which is 6809.98% down from last year.
- As of Q4 2025, InMed Pharmaceuticals' Enterprise Value stood at -$7.0 million, which was down 2522.92% from -$9.4 million recorded in Q3 2025.
- InMed Pharmaceuticals' Enterprise Value's 5-year high stood at -$4.7 million during Q1 2025, with a 5-year trough of -$15.4 million in Q3 2021.
- Over the past 5 years, InMed Pharmaceuticals' median Enterprise Value value was -$8.3 million (recorded in 2023), while the average stood at -$8.5 million.
- Per our database at Business Quant, InMed Pharmaceuticals' Enterprise Value soared by 4129.24% in 2024 and then plummeted by 6809.98% in 2025.
- Over the past 5 years, InMed Pharmaceuticals' Enterprise Value (Quarter) stood at -$11.3 million in 2021, then fell by 1.5% to -$11.5 million in 2022, then grew by 16.67% to -$9.6 million in 2023, then soared by 41.29% to -$5.6 million in 2024, then fell by 25.23% to -$7.0 million in 2025.
- Its Enterprise Value stands at -$7.0 million for Q4 2025, versus -$9.4 million for Q3 2025 and -$11.1 million for Q2 2025.